Amaryl is indicated for the treatment of type 2 diabetes mellitus, when diet, exercise and weight reduction alone are not sufficient.
The basis of optimal diabetes treatment must be a controlled diet, regular physical exercise, as well as systematic control of blood sugar and glycosuria. Oral antidiabetics or insulin cannot compensate for the patient's failure to comply with the diet.
The starting dose is 1 mg of glimepiride per day. If the control achieved is satisfactory, this dosage can be adopted as maintenance therapy.
If control is not satisfactory, the dose should be increased based on glycemic control, gradually with an interval of approximately 1-2 weeks for each increase, up to 2, 3 or 4 mg of glimepiride per day.
A dose higher than 4 mg per day of glimepiride leads to better therapeutic results only in exceptional cases. The maximum recommended dose of glimepiride is 6 mg per day.
Effects of metformin plus gliclazide versus metformin plus glimepiride on cardiovascular risk factors in patients with; clinical profile of glimepiride. Efficacy and safety of insulin glargine and glimepiride in subjects with type 2; amaryl (glimepiride) is an oral diabetes medicine that helps control blood sugar levels.
Efficacy and safety of once-weekly dulaglutide versus insulin glargine in patients with type 2 diabetes on metformin and glimepiride (award-2). Efficacy of glimepiride in patients with poorly controlled insulin-treated type 2 diabetes mellitus. Email; print; help. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate; USA Sale 2024 exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure;
